Novo Nordisk | NVO - Market Capitalization


Novo Nordisk reported DKK148.02B in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
ANI Pharmaceuticals USD 1.75B 24M Mar/2026
Aurora Cannabis CAD 327.21M 142.93M Dec/2025
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Canopy Growth CAD 656.46M 124.89M Dec/2025
Corcept Therapeutics USD 4.32B 654M Mar/2026
Eli Lilly USD 869.02B 146.97B Mar/2026
GlaxoSmithKline GBP 83.8B 9.44B Mar/2026
Merck USD 297.1B 35.84B Mar/2026
Nektar Therapeutics USD 11.91B 11.05B Jun/2026
Novartis USD 307.76B 15.54B Mar/2026
Novo Nordisk A/S DKK 1.03T 421.31B Mar/2026
Pacira USD 915M 149M Mar/2026
Perrigo USD 1.31B 604M Mar/2026
Phibro Animal Health USD 1.51B 126M Dec/2025
Prestige Brands USD 2.8B 161M Mar/2026
Sanofi EUR 100.27B 605.48M Mar/2026
Supernus Pharmaceuticals USD 2.98B 126M Mar/2026
Zoetis USD 49.71B 5.74B Mar/2026